ANDA 85894, held by Watson Labs. Phenytoin Sodium.
As of Nov 16, 2026, ANDA 85894 (Phenytoin Sodium), held by Watson Labs, was first approved by FDA on May 11, 1979, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 11, 1979 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phenytoin Sodium100MG PROMPT ยท capsule;oral | Phenytoin Sodium | Discontinued |
| Apr 14, 1988 | Supplement 17Labeling | Approved | None posted |
| May 11, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters